Jonathan Li, MD, MS

Title(s)RESIDENT, Surgery
SchoolSchool of Medicine
Address35 Medical Center Way, #001
San Francisco CA 94143
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Berkeley, Berkeley, CABA05/2017Molecular and Cell Biology
    University of California, San Francisco, San Francisco, CAMD05/2024Medicine
    University of California, San Francisco, San Francisco, CAMAS05/2024Clinical and Epidemiologic Research
    Collapse Awards and Honors
    UCSF2024Long Term Dean's Prize Finalist
    AASLD2023Early Career Investigator Award in Clinical/Translational Science
    ACTS2023TL1 Blue Ribbon Award
    Burroughs Wellcome Fund2023Burroughs Wellcome Fund Trainee Travel Award
    UCSF2022  - 2023UCSF Yearlong Research Fellowship

    Collapse Overview 
    Collapse Overview
    (Po-Yi) Jonathan Li is a first-year general surgery resident at UCSF. He completed his B.A. at the University of California, Berkeley where he studied Molecular and Cell Biology with a focus in immunology. He spent 2 years developing non-viral CRISPR gene editing and screening technologies to improve cancer cell therapies before attending medical school at the University of California, San Francisco. During medical school, he took a funded research year to study predictive risk models for HCC waitlist and transplant outcomes and concurrently completed a Master’s in Clinical and Epidemiologic Research.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients with Pancreatic Ductal Adenocarcinoma. Ann Surg. 2024 Aug 23. Wang J, Ashraf Ganjouei A, Romero-Hernandez F, Foroutani L, Bahceci D, Deranteriassian A, Casey M, Li PY, Houshmand S, Behr S, Jamshidi N, Majumdar S, Donahue T, Kim GE, Wang ZJ, Thornblade LW, Adam M, Alseidi A. PMID: 39176476.
      View in: PubMed   Mentions:    Fields:    
    2. Recent Advances in Liver Transplantation for Hepatocellular Carcinoma. Curr Treat Options Oncol. 2024 Sep; 25(9):1153-1162. Li PJ, Shah S, Mehta N. PMID: 39085572; PMCID: PMC11416390.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Development and validation of a biomarker index for HCC treatment response. Hepatol Commun. 2024 07 01; 8(7). Liang J, Li PY, Norman J, Lauzon M, Yeo YH, Trivedi H, Ayoub WS, Kuo A, Friedman ML, Sankar K, Gong J, Osipov A, Hendifar A, Todo T, Kim I, Voidonikolas G, Brennan TV, Wisel SA, Steggarda J, Kosari K, Saouaf R, Nissen N, Yao F, Mehta N, Yang JD. PMID: 38896084; PMCID: PMC11186807.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation. J Hepatol. 2023 12; 79(6):1469-1477. Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N. PMID: 37683735; PMCID: PMC10998694.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    5. AFP-L3 and DCP are superior to AFP in predicting waitlist dropout in HCC patients: Results of a prospective study. Liver Transpl. 2023 10 01; 29(10):1041-1049. Mehta N, Kotwani P, Norman J, Shui A, Li PJ, Saxena V, Chan W, Yao FY. PMID: 37159217; PMCID: PMC10523909.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma. Am J Clin Pathol. 2021 Mar 15; 155(4):515-521. Balcerek J, Trejo E, Levine K, Couey P, Kornberg ZV, Rogine C, Young C, Li PJ, Shy BR, Taylor JE, Bakhtary S, Friedlander T, Lynch KL, Bern C, Esensten JH. PMID: 33399201; PMCID: PMC7929413.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models. Cancers (Basel). 2021 Feb 09; 13(4). Li PJ, Roose JP, Jablons DM, Kratz JR. PMID: 33572297; PMCID: PMC7915264.
      View in: PubMed   Mentions: 1  
    8. Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies. Cell. 2020 Apr 30; 181(3):728-744.e21. Roth TL, Li PJ, Blaeschke F, Nies JF, Apathy R, Mowery C, Yu R, Nguyen MLT, Lee Y, Truong A, Hiatt J, Wu D, Nguyen DN, Goodman D, Bluestone JA, Ye CJ, Roybal K, Shifrut E, Marson A. PMID: 32302591; PMCID: PMC7219528.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansAnimalsCells
    9. Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency. Nat Biotechnol. 2020 Jan; 38(1):44-49. Nguyen DN, Roth TL, Li PJ, Chen PA, Apathy R, Mamedov MR, Vo LT, Tobin VR, Goodman D, Shifrut E, Bluestone JA, Puck JM, Szoka FC, Marson A. PMID: 31819258; PMCID: PMC6954310.
      View in: PubMed   Mentions: 125     Fields:    Translation:Humans
    10. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function. Cell. 2018 12 13; 175(7):1958-1971.e15. Shifrut E, Carnevale J, Tobin V, Roth TL, Woo JM, Bui CT, Li PJ, Diolaiti ME, Ashworth A, Marson A. PMID: 30449619; PMCID: PMC6689405.
      View in: PubMed   Mentions: 249     Fields:    Translation:HumansCells
    11. Reprogramming human T cell function and specificity with non-viral genome targeting. Nature. 2018 07; 559(7714):405-409. Roth TL, Puig-Saus C, Yu R, Shifrut E, Carnevale J, Li PJ, Hiatt J, Saco J, Krystofinski P, Li H, Tobin V, Nguyen DN, Lee MR, Putnam AL, Ferris AL, Chen JW, Schickel JN, Pellerin L, Carmody D, Alkorta-Aranburu G, Del Gaudio D, Matsumoto H, Morell M, Mao Y, Cho M, Quadros RM, Gurumurthy CB, Smith B, Haugwitz M, Hughes SH, Weissman JS, Schumann K, Esensten JH, May AP, Ashworth A, Kupfer GM, Greeley SAW, Bacchetta R, Meffre E, Roncarolo MG, Romberg N, Herold KC, Ribas A, Leonetti MD, Marson A. PMID: 29995861; PMCID: PMC6239417.
      View in: PubMed   Mentions: 386     Fields:    Translation:HumansAnimalsCells
    12. Tumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages. Elife. 2018 05 14; 7. Thompson TW, Jackson BT, Li PJ, Wang J, Kim AB, Huang KTH, Zhang L, Raulet DH. PMID: 29757143; PMCID: PMC5991831.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    13. Endothelial cells express NKG2D ligands and desensitize antitumor NK responses. Elife. 2017 12 12; 6. Thompson TW, Kim AB, Li PJ, Wang J, Jackson BT, Huang KTH, Zhang L, Raulet DH. PMID: 29231815; PMCID: PMC5792093.
      View in: PubMed   Mentions: 43     Fields:    Translation:AnimalsCells
    Jonathan's Networks
    Concepts (68)
    Derived automatically from this person's publications.
    _
    Co-Authors (42)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _